CLINICAL SUPPLY MANAGEMENT ARTICLES
6 Risks To Clinical Supply Spurred By 'Once In A Lifetime' Lp(a) Screening
Expert-recommended "once‑in‑a‑lifetime" testing for Lp(a) introduces new clinical supply risks as screening drives volatility, longer treatment, and inventory strain.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
As early phase clinical trials become more sophisticated, sponsors are now leveraging flexible IRT solutions to replace error-prone manual processes and gain greater control and efficiency.
-
Gain insight into why pharma companies generally seek IRT vendor relationships to ensure high-quality builds that meet their needs and avoid the potential pitfalls associated with RTSM.
-
An inside look at a clinical-stage company focused on bringing its gene therapy from the lab into a clinical setting for patients and families devastated by rare neurological genetic diseases.
-
Explore how scenario planning enables you to find the best strategy while balancing risks and costs and gives you the ability to arm your internal stakeholders with impact assessment data based on plausible scenarios.
-
Examine a COVID-19 treatment trial that utilized integrated EDC, eConsent, eCOA, RTSM, and TeleVisit solutions, all within a single platform, to address three critical challenges.
-
Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.
-
Streamline clinical supply chain management with SmartSignals Supplies, reducing errors and inefficiencies from spreadsheet-based forecasting.